Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Specimen Handling 6Tamoxifen 4ruxolitinib 1pembrolizumab 1exemestane 1Watchful Waiting 1Surveys and Questionnaires 1Starch 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Protons 1Proton Therapy 1Omacor 1Observation 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Laser Therapy 1Interviews as Topic 1Hypnosis, Anesthetic 1Genotype 1Educational Status 1Early Intervention, Educational 1Decision Support Techniques 1Counseling 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Genotype × 90 days × Clear all
NCT05755269 2026-05-01

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Mayo Clinic

Terminated
19 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡